Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is expected to experience significant earnings growth, driven by their plans to reduce leverage and increase earnings through selling OMF assets and acquiring more SHOP properties. With a strong senior housing market and a goal to become a full SHOP portfolio, NHP's recent IPO has improved their leverage and they plan to pay a dividend. Their strategy of growth through acquisitions and focus on middle market communities makes their assets highly desirable, however, they may face risks such as market conditions and changes in healthcare delivery.

Bears say

National Healthcare is transitioning to a full SHOP portfolio, but has a relatively small portfolio and lacks a strong track record in this sector. Their OMF portfolio has underperformed compared to SHOP and carries elevated recurring capex, which negatively affects FAD per share. The company has a high risk of needing external capital in the coming years, and the pandemic has created additional uncertainty as senior housing demand and labor availability may contract. Additionally, the expiration of the lock-up period for legacy shareholders could lead to a significant selling pressure.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Jul 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.